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Abstract
Patients undergoing cochlear implant after prior radical mastoidectomy are at
increased risk of device infection requiring device explant. Various techniques
including two-stage operations have been used. We report the novel technique
with use of a vascularized fascia lata free flap for a patient undergoing cochlear
implantation with radical mastoidectomy.
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1 | I N T RO DU CT ION /
BAC KG RO U ND
Cochlear implantation is now the standard of care for patients with severe to profound sensorineural hearing loss
in whom hearing aids are no longer beneficial. Patients
undergoing cochlear implantation (CI) after prior radical
mastoidectomy are at increased risk of device infection, a
potentially devastating complication requiring device explant. The open mastoid cavity can lead to extrusion of the
electrode and device failure. There is also a concern for

increased risk of infection leading to labyrinthitis or meningitis given the altered anatomy and underlying chronic
ear disease. Various techniques including two-stage operations have been used in patients with radical mastoidectomy anatomy in order to mitigate those risks. CI in
patients who have undergone previous canal wall down
(CWD) mastoidectomy can be a challenging problem.
There exist several strategies in technique to overcome
the challenge of CI in patients with previous CWD mastoidectomy. The particular challenge faced when performing CI in a patient who has previously undergone
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CWD mastoidectomy revolves around the higher rate of
electrode or device extrusion. Strategies to overcome this
problem include soft tissue coverage of the electrode,
overclosure of the external auditory meatus (EAM) with
and without mastoid obliteration or eustachian tube (ET)
plugging, and reconstruction of the posterior external
auditory canal wall.1–5 The advent of several new techniques in recent years has met with varying degrees of
success. Other options include the use of the middle fossa
approach to the cochlea, while other surgeons have advocated for the partial obliteration of the mastoid cavity
using tragal cartilage and bone paté with success.6–8
Free flap reconstruction has previously been reported
in patients with CWD mastoidectomy with a history of
osteoradionecrosis and profound hearing loss.9 Free flap
reconstruction is an excellent option to placed vascularized tissue in an area that has often been subject to
chronic inflammation. The team approach for free flap
reconstruction allows for an excellent option for cochlear
implantation in a patient who has previously undergone
CWD mastoidectomy. Surgical planning is key to this
approach.
Here, we report the novel technique of a single-stage
procedure for cochlear implantation in a patient with
canal wall down mastoidectomy anatomy with the use of
a vascularized fascia lata-free flap. This case follows the
clinical course of a previously healthy man with a history of left CWD mastoidectomy and eventual combined
transotic, middle fossa, and suboccipital approach on the
left side, with complete removal of the cochlea and vestibule. He also had a history of right CWD mastoidectomy
with a large meatoplasty previously performed. He had a
history of bilateral profound sensorineural hearing loss.
This report describes the team approach to free flap reconstruction with fascia lata-free flap reconstruction for
simultaneous coverage and obliteration of CWD mastoidectomy in a patient undergoing cochlear implantation.
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physical examination, his bilateral mastoid cavities were
stable without active infection, with an intact tympanic
membrane on the right side.
Given the extensive surgery on the left side with prior
removal of the vestibule and cochlea, right-sided cochlear
implantation was pursued. However, due to his previous
right-sided ear surgeries, he had limited soft tissue coverage over the anticipated implant site. The patient had a
wide meatoplasty which would make creation of a blind
sac difficult (Figure 1). Plans for fascia lata-free flap based
on the descending branch of the lateral femoral circumflex
artery for coverage of the implant and obliteration of the
mastoid and middle ear cavities were made (Figures 2,3).10
Intraoperatively, the right ear canal blind sac was created but noted to be tenuous. The squamous epithelium
lining the bony canal and tympanic membrane was removed. The previous mastoid cavity was revised, and all
mucosa was then removed from the mastoid and middle
ear (Figure 4). The eustachian tube was plugged with muscle. The receiver stimulator was then placed in a tight subperiosteal pocket, and the electrode was inserted through
the round window with full insertion (Figure 5).

FIGURE 1

CWD with large meatoplasty

FIGURE 2

ALT flap with excess tissue trimmed

C A S E RE PORT

A 61-year-old male patient presented to us with right
moderately severe to profound sensorineural hearing loss
(SNHL) and left profound SNHL. He had a word recognition score of 48% in the right ear and no hearing in the left.
He had a history of right CWD mastoidectomy for cholesteatoma performed 20 years prior. He also had extensive
surgery on the left side 39 years ago. A CT scan was obtained confirming the right CWD mastoid cavity, but also
evidence of a combined transotic, middle fossa, and suboccipital approach on the left side, with complete removal
of the cochlea and vestibule. It was unclear what the exact
pathology was on the left side requiring such surgery. On
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Partial inset of free flap
FIGURE 5

Electrode in position in mastoid cavity

FIGURE 6

ALT-free flap in position with good coverage

ERound window

Following implantation, a left fascia lata-free flap was
harvested as described above and anastomosed to the right
facial artery and vein.10 This vascularized fascial flap was
then used to obliterate the middle ear and mastoid bowl,
provide coverage to the cochlear implant receiver stimulator and electrode, and reinforce the blind sac closure of the
ear canal (Figure 6). The patient was kept in the hospital
and discharged in good condition on post-operative Day 3.
The patient returned for follow-up in the office 2 weeks
later for device activation. The implant was in good position with healthy overlying skin and a well-healed blind
sac. At the time of writing, it has been 7 months since surgery, and the patient has continued to improve with his
cochlear implant with no signs of wound breakdown, infection, or recurrent cholesteatoma.
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DI S C USSION S/ CON CLU SIO NS

Chronic otitis media and cholesteatoma leading to radical
mastoidectomy present a unique challenge for cochlear

implantation. Cochlear implantation has become the
standard of care for patients with severe to profound
sensorineural hearing loss in whom hearing aids are no
longer beneficial. Patients who have profound sensorineural hearing loss and a previous history of CWD mastoidectomy present a unique challenge. These patients are
at higher risk for device infection, extrusion, and possible need for explantation. This is a result of exposure of
the electrode and device to the environment via the previously created mastoid cavity. Several techniques have
been developed to mitigate this risk. Options include EAC
overclosure or blind-sac closure of the EAC. Other options
include partial obliteration of the mastoid cavity, middle
fossa approach to the cochlea, and the use of a two-stage
procedure. Ugo Fisch described subtotal petrosectomy
in 1965. This technique has been reported by several authors for cochlear implantation in patients with CWD
mastoidectomy.6
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The risk of CI in patients with previous CWD mastoidectomy consists primarily of the risk of device infection
and need for subsequent explanation and the risk of electrode or device extrusion. Other challenges inherent to
implantation in patients who have previously undergone
CWD mastoidectomy include risk of infection and meningitis. This is in addition to the risk of electrode and device
extrusion. Several techniques have been developed to help
mitigate this risk.
Overclosure of the EAC is a common strategy for patients with a prior CWD mastoidectomy undergoing cochlear implantation. However, studies have shown an
increased risk of complications and dehiscence in patients
with a large meatoplasty.3 The complication rate for patients who do not undergo overclosure of the EAC is much
higher still. Undetected cholesteatoma is a possible risk
for patients who undergo EAC overclosure. This is particularly problematic since it would be difficult to detect with
a masked cavity.
A technique that has been developed to deal with the
risks and complications of EAC overclosure include a technique of partially obliterating the mastoid cavity. There
are various techniques to accomplish this such as the use
cartilage and bone paté.6 There still other options as well
for avoiding EAC overclosure. These other options include
reconstruction of the posterior canal wall and middle
fossa approaches.7,8 Two-stage procedures have been used
as an option for this patient population. However, there
are disadvantages and risks as outlined above.
Other techniques described include maintaining an
open mastoid cavity with soft tissue coverage of the electrode, posterior canal wall reconstruction, and mastoid
obliteration with ET plugging and blind sac closure of the
EAM. There is potential to better monitor for recurrence
of disease by maintaining an open cavity. The technique
described in these cases includes partial obliteration of the
mastoid bowl with bone pate and cartilage, or the use of
pedicled muscle or periosteal flaps to provide soft tissue
coverage to the electrode as it passes through the mastoid
cavity.3,6,11 Caution is needed with future mastoid bowl
cleanings in this patient population.
Mastoid obliteration with ET plugging and EAM closure is a commonly described technique (Video S1). This
can be performed as a single or two-
stage operation.
Single-stage procedures are only considered in a stable,
dry ear. Two-stage operations are performed when there
is active disease or high suspicion for recurrent disease.
Various materials have been described for obliteration
including bone pate, muscle, or abdominal fat. Benefits
of mastoid obliteration with ET plugging and EAM closure include decreased rate of extrusion.3 However, it
does prevent monitoring for recurrent disease. Given the

nature of the chronic disease, long-term follow-up is necessary to prevent unrecognized recurrent disease.12 CT
follow-up has been proposed to monitor for recurrence;
however, the sensitivity is low in detecting recurrent cholesteatoma.11,13,14 Another difficulty with this approach is
maintaining EAM closure in the setting of previous large
meatoplasty. Common complications in these procedures
included dehiscence of the blind sac.3,6,14–16 This was
anticipated in our case and countered with the free flap
reinforcement.
The use of fascia lata-free flap allowed for a single-stage
procedure for this patient. The free flap allowed for simultaneous coverage for the obliterated mastoid cavity and
good soft tissue reinforcement for blind-sac of the EAC
even though the patient had large meatoplasty (Video
S2). The use of the fascia-free flap in this case greatly lessened the risk of dehiscence of the blind-sac EAC. We also
stripped all mucosa from the middle ear space and packed
the eustachian tube as well as part of the blind-sac procedure. The use of a simultaneous free flap allowed for
single-stage procedure for both cochlear implantation and
reconstruction of the obliterated mastoid cavity and blind-
sac EAC.
The fascia lata-free flap was a great option for vascularized tissue to reinforce and greatly decrease the risk of
dehiscence of the blind-sac EAC in this patient with prior
CWD mastoidectomy and large meatoplasty. This is an
excellent option for appropriately selected patients with
canal wall down mastoidectomy anatomy undergoing cochlear implantation. Having robust soft tissue coverage
and reinforcement as well as close follow-up will provide
the best outcomes: a successful implantation.
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